[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9602837A - Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. - Google Patents

Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.

Info

Publication number
MX9602837A
MX9602837A MX9602837A MX9602837A MX9602837A MX 9602837 A MX9602837 A MX 9602837A MX 9602837 A MX9602837 A MX 9602837A MX 9602837 A MX9602837 A MX 9602837A MX 9602837 A MX9602837 A MX 9602837A
Authority
MX
Mexico
Prior art keywords
cosmetic
derivatives
pharmaceutical compositions
compositions containing
containing mangiferin
Prior art date
Application number
MX9602837A
Other languages
English (en)
Inventor
Francoise Rouillard
Annabelle Josse
Jean-Renaud Robin
Original Assignee
Rocher Yves Biolog Vegetale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9414176A external-priority patent/FR2727313A1/fr
Priority claimed from FR9503513A external-priority patent/FR2731906B1/fr
Priority claimed from FR9507508A external-priority patent/FR2735695B1/fr
Application filed by Rocher Yves Biolog Vegetale filed Critical Rocher Yves Biolog Vegetale
Publication of MX9602837A publication Critical patent/MX9602837A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion tiene por objetivo una composicion cosmética o farmacéutica que comprende, a manera de principio activo, un compuesto de la formula general I, en donde R1, R2, R3, R4, R5, R6, R7, R8, se eligen de entre -H, -OH, -OCH, -OCH3 y un radical glucosilo, o una de sus sales farmacéuticas.
MX9602837A 1994-11-25 1995-11-23 Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. MX9602837A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9414176A FR2727313A1 (fr) 1994-11-25 1994-11-25 Composition cosmetique a base d'un extrait d'aphloia
FR9503513A FR2731906B1 (fr) 1995-03-24 1995-03-24 Composition cosmetique a base d'un extrait de mangifera
FR9507508A FR2735695B1 (fr) 1995-06-22 1995-06-22 Compositions cosmetiques ou pharmaceutiques contenant a titre de principe actif, de la mangiferine ou ses derives
PCT/FR1995/001552 WO1996016632A1 (fr) 1994-11-25 1995-11-23 Compositions cosmetiques ou pharmaceutiques contenant de la mangiferine ou ses derives

Publications (1)

Publication Number Publication Date
MX9602837A true MX9602837A (es) 1997-06-28

Family

ID=27252988

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602837A MX9602837A (es) 1994-11-25 1995-11-23 Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.

Country Status (11)

Country Link
US (1) US5824320A (es)
EP (1) EP0793476B1 (es)
JP (1) JP2858961B2 (es)
AT (1) ATE206611T1 (es)
AU (1) AU4264396A (es)
CA (1) CA2180745A1 (es)
DE (1) DE69523169T2 (es)
MX (1) MX9602837A (es)
NO (1) NO963053L (es)
PL (1) PL315636A1 (es)
WO (1) WO1996016632A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000667A1 (en) * 1995-06-22 1997-01-09 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6623744B2 (en) 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
PL186769B1 (pl) * 1995-09-07 2004-02-27 Oreal Zastosowanie wyciągu z Iridaceae i kompozycja zawierająca taki wyciąg
US6582711B1 (en) * 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
CU22846A1 (es) * 1998-12-29 2003-04-28 Ct De Quimica Farmaceutica Composiciones farmacéuticas y nutricionales a partir de extractos de mangifera indica l
WO2000051562A1 (en) * 1999-03-03 2000-09-08 Shiseido Company, Ltd. Matrix metalloprotease inhibitor and utilization thereof
US6630163B1 (en) 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
US6800292B1 (en) 1999-04-22 2004-10-05 Howard Murad Pomegranate fruit extract compositions for treating dermatological disorders
US7179912B2 (en) 2000-09-01 2007-02-20 Icos Corporation Materials and methods to potentiate cancer treatment
US8404681B2 (en) 2003-03-24 2013-03-26 Luitpold Pharmaceuticals, Inc. Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
CA2540085C (en) 2003-09-29 2010-11-16 Bruce Michael Koivisto High alcohol content gel-like and foaming compositions
FR2868308B1 (fr) * 2004-04-06 2006-06-02 Biolog Vegetale Yves Rocher Sa Composition cosmetique blanchissante contenant un extrait d'alphloia en association avec au moins un autre extrait de plante a activite blanchissante
FR2871061B1 (fr) * 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
FR2876906B1 (fr) * 2004-10-21 2007-04-13 Biolog Vegetale Yves Rocher Sa Utilisation cosmetique de mangiferine
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
JP2006188463A (ja) * 2005-01-07 2006-07-20 Ichimaru Pharcos Co Ltd メラニン生成抑制剤およびそれを配合する化粧料組成物
FR2882762B1 (fr) * 2005-03-04 2007-06-15 Biolog Vegetale Yves Rocher Sa Synthese d'un derive sucre de mangiferine
KR101512843B1 (ko) 2005-03-07 2015-04-16 디이비 월드와이드 헬스케어 인코포레이티드 실리콘-기제 계면활성제를 갖는 고함량 알코올 폼 형성조성물
WO2006122158A2 (en) * 2005-05-10 2006-11-16 Xanthone Plus International, Llc Skin care compositions containing xanthones
US7651990B2 (en) * 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
CN101229181A (zh) * 2006-09-12 2008-07-30 徐广爱 具有糖尿病及其并发症治疗作用的药物组合物
US9072717B2 (en) * 2007-09-18 2015-07-07 Elc Management Llc Cosmetic compositions containing alpha glucosidase inhibitors and methods of use
JP4365452B2 (ja) 2007-10-18 2009-11-18 株式会社資生堂 紫外線防御効果の評価方法、評価装置、評価プログラム、及び該プログラムが記録された記録媒体
US20110177014A1 (en) * 2008-04-01 2011-07-21 Biopharmacopae Design International Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection
JP2011195502A (ja) * 2010-03-19 2011-10-06 Shiseido Co Ltd 線維芽細胞増殖促進剤、抗老化剤及びしわ改善剤
CN101885723A (zh) * 2010-07-09 2010-11-17 广西中医学院 芒果苷糖酯衍生物及其制备方法
JP5006958B2 (ja) * 2010-09-17 2012-08-22 株式会社 資生堂 紫外線防御効果の評価方法、評価装置、評価プログラム、及び該プログラムが記録された記録媒体
CN102863484B (zh) * 2011-07-06 2014-04-23 南京工业大学 果糖基化芒果苷及其制备方法与用途
CN102432602B (zh) * 2011-10-24 2014-07-02 广西中医药大学 芒果苷七丙酯化衍生物
CN102491963A (zh) * 2011-11-23 2012-06-13 常州亚当生物技术有限公司 化合物i和ii及其其制备治疗抑制黑色素形成药物中的应用与制备方法
ES2464192B1 (es) * 2012-11-30 2015-06-11 Universidad De Cádiz Extractos fenólicos de Mangifera indica Linn, procedimiento de obtención y usos.
CN103655381B (zh) * 2013-12-27 2015-12-09 茂名职业技术学院 一种从芒果叶或橘叶中提取防晒成分的方法
CN104211690B (zh) * 2014-08-27 2017-05-03 中山市格好生物科技发展有限公司 一种从白木香树叶中分离纯化芒果苷的方法
CN104311614B (zh) * 2014-11-05 2016-07-20 桂林益元素生物科技有限公司 一种从芒果叶中提取芒果甙的方法
FR3042708B1 (fr) * 2015-10-23 2018-12-07 Laboratoires De Biologie Vegetale Yves Rocher Utilisation de la mangiferine dans une composition cosmetique pour une action sur la differenciation de l'epiderme et ses fonctions
RU2634347C1 (ru) * 2016-09-21 2017-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный медицинский университет" Министерства здравоохранения Российской Федерации Лечебно-профилактическая зубная паста
US10898420B2 (en) 2016-10-31 2021-01-26 L'oreal Compositions containing phenolic compounds having synergistic antioxidant benefits
US10828515B2 (en) 2016-10-31 2020-11-10 L'oreal Compositions containing phenolic compounds having synergistic antioxidant benefits
US10624830B2 (en) * 2017-11-30 2020-04-21 L'oreal Aqueous compositions with mangiferin for cosmetic applications
GB2576301A (en) * 2018-07-06 2020-02-19 Clement Idowu Olusola Mangiferin-containing skin-care compositions and methods
US20210106601A1 (en) * 2018-01-30 2021-04-15 Olusola Clement Idowu Mangiferin as a protective agent against mitochondrial dna damage and skin-care compositions comprising same
PL243667B1 (pl) * 2020-04-22 2023-09-25 Univ Jagiellonski Pochodne ksantonu, koncentrat kompozycji promieniochronnej, sposób otrzymywania koncentratu kompozycji promieniochronnej, zastosowanie koncentratu kompozycji promieniochronnej i kosmetyczny produkt promieniochronny
CN111803421A (zh) * 2020-08-13 2020-10-23 苏格格 保湿美白护肤霜
CN112608305B (zh) * 2020-12-21 2022-06-21 浙江工业大学 一种芒果苷衍生物及其制备方法与在美白产品中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5152M (es) * 1965-11-16 1967-06-12
US4217341A (en) * 1977-12-07 1980-08-12 The University of Louisville Composition and method for inhibiting the adherence of dental plaque-producing bacteria to smooth surfaces
GB2082170B (en) * 1980-07-16 1984-03-28 Vnii Lekarstvenny Process for preparing mangiferin
FR2509988B1 (fr) * 1981-07-23 1986-05-30 Oreal Melange d'huiles vegetales a base d'huile de jojoba comme agent de stabilisation a l'oxydation et compositions cosmetiques le contenant
DE3141970A1 (de) * 1981-10-22 1983-05-05 Vsesojuznyj naučno-issledovatel'skij institut lekarstvennych rastenij, Vilar, Moskovskaja oblast' Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen

Also Published As

Publication number Publication date
NO963053D0 (no) 1996-07-22
ATE206611T1 (de) 2001-10-15
PL315636A1 (en) 1996-11-25
CA2180745A1 (fr) 1996-06-06
EP0793476B1 (fr) 2001-10-10
WO1996016632A1 (fr) 1996-06-06
DE69523169D1 (de) 2001-11-15
EP0793476A1 (fr) 1997-09-10
DE69523169T2 (de) 2002-05-16
JPH09506906A (ja) 1997-07-08
AU4264396A (en) 1996-06-19
JP2858961B2 (ja) 1999-02-17
NO963053L (no) 1996-09-20
US5824320A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
MY116845A (en) New 19-nor-pregnene derivatives
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
NO996108L (no) 9-oksinerytromycinderivater
TR200103395T2 (tr) 13-metil eritromisin türevleri.
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
DE69317877D1 (en) 4''-deoxyerythromycinderivate
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DE69330601D1 (de) Serotoninergische ergolin derivate
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
NZ240441A (en) Thiazol- or thiadiazol-substituted 7-acyl-3-substituted carbamoyloxy cephem derivatives and antibacterial compositions thereof; cephem intermediates
AP9801235A0 (en) Erythromycin derivatives.
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
NZ243784A (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkane derivatives and pharmaceutical compositions
TW371302B (en) Cosmetic compositions containing, as active ingredient, mangiferine or its derivatives in pure form
IL116557A0 (en) Antiherpes peptidomimetic compounds their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees